Conmed (CNMD) Tops Q3 Earnings and Revenue Estimates

Core Viewpoint - Conmed (CNMD) reported quarterly earnings of $1.08 per share, exceeding the Zacks Consensus Estimate of $1.05 per share, and showing a slight increase from $1.05 per share a year ago, indicating a positive earnings surprise of +2.86% [1] Financial Performance - The company achieved revenues of $337.93 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 0.42% and reflecting a year-over-year increase from $316.7 million [2] - Over the last four quarters, Conmed has consistently exceeded consensus EPS and revenue estimates [2] Stock Performance - Conmed shares have declined approximately 33.2% since the beginning of the year, contrasting with the S&P 500's gain of 15.1% [3] - The current Zacks Rank for Conmed is 3 (Hold), suggesting that the stock is expected to perform in line with the market in the near future [6] Earnings Outlook - The consensus EPS estimate for the upcoming quarter is $1.31 on revenues of $368.68 million, and for the current fiscal year, it is $4.47 on revenues of $1.37 billion [7] - The trend of earnings estimate revisions for Conmed was mixed prior to the earnings release, which may influence future stock performance [6] Industry Context - The Medical - Dental Supplies industry, to which Conmed belongs, is currently ranked in the top 24% of over 250 Zacks industries, indicating a favorable outlook compared to lower-ranked industries [8]